Knowledge

Essential Medicines

WHPA Health Improvement Card

Database

Improving global health through positive changes in behaviour and lifestyle, to reduce the 36 million death burden from non-communicable diseases.

Published by: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

World Cancer Report: Cancer Research for Cancer Prevention

Report

The report focuses on prevention and offers the most comprehensive overview of relevant research avaliable to date, ranging from descriptive etiology, cellular and molecular biology, toxicology and pathology through to behavioural and social sciences. Key chapters include discussions on the impact of inequities in cancer, vaccination and screening, genomic individual susceptibility to cancer and the finer identification of those at risk, which may allow 'precision cancer prevention'.

Published by: International Agency for Research on Cancer

Global Hearts Initiative

Fact sheet

To support governments in strengthening the prevention and control of cardiovascular diseases (CVDs), in 2016 WHO and the United States Centers for Disease Control and Prevention (US CDC) launched the Global Hearts Initiative.

The Initiative comprises five technical packages which provide a set of high-impact, evidence-based interventions that, when used together, will have a major impact on improving global heart health.

Published by: World Health Organization (WHO)

Universal Health Coverage and Palliative Care: Do not leave those suffering behind

Report

 

This report, published on the first-ever Universal Health Coverage Day, highlights the current situation in relation to hospice and palliative care and UHC and makes recommendations for working towards the greater inclusion of palliative care within Universal Health Coverage policies and schemes.

Published by: Worldwide Hospice and Palliative Care Alliance

Follow-up to the high-level meetings of the United Nations General Assembly on NCDs

Report

The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.

Published by: World Health Organization (WHO)

Follow-up to the high-level meetings of the United Nations General Assembly on NCDs

Report

The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.

Published by: World Health Organization (WHO)

Follow-up to the high-level meetings of the United Nations General Assembly on NCDs

Report

The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.

Published by: World Health Organization (WHO)

Follow-up to the high-level meetings of the United Nations General Assembly on NCDs

Report

The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.

Published by: World Health Organization (WHO)

Follow-up to the high-level meetings of the United Nations General Assembly on NCDs

Report

The report is submitted in response to resolution WHA71.2 (2018), which “requests the Director-General to report to the Seventy-second World Health Assembly, through the Executive Board, on the outcomes of the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and its follow-up.

Published by: World Health Organization (WHO)

Exploring the Expansion of the Medicines Patent Pool’s Mandate to Patented Essential Medicines: A Feasibility Study of the Public Health Needs and Potential Impact

Case study

The Medicines Patent Pool (MPP) conducted a feasibility study to assess the public health need for – and the feasibility and potential public health impact of – expanding its mandate from HIV, tuberculosis and hepatitis C to patented essential medicines in other therapeutic areas. This includes medicines for different type of cancers (e.g. prostate, lung, multiple myeloma), sexual and reproductive health (e.g. heat-stable carbetocin), multiple sclerosis, cardiovascular diseases (e.g. the direct oral anticoagulants) and several new antibiotics.

MPP developed this feasibility study after the World Health Organization (WHO) and the Lancet Commission on Essential Medicines Policies, recommended the expansion of the MPP’s patent pooling model to all patented essential medicines, such as those included on the WHO Model List of Essential Medicines.

Published by: Medicines Patent Pool (MPP)

General Meeting of the WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: Meeting Report

Report

On 5–6 November 2018, the first General Meeting of the GCM/NCD was held in Geneva, Switzerland, to reinforce the commitment of the participants to accelerated multisectoral and multistakeholder action to achieve SDG target 3.4

Published by: World Health Organization

Access to Essential Medicines and Equipment

Case study

Case studies compiled as part of the work of the NCD Child Taskforce on Essential Medicines and Equipment.

Published by: NCD Child

Fact Sheet: Palliative Care

Fact sheet

Palliative care is an approach that improves the quality of life of patients (adults and children) and their families who are facing problems associated with life-threatening illness. It prevents and relieves suffering through the early identification, correct assessment and treatment of pain and other problems, whether physical, psychosocial or spiritual.

Published by: World Health Organization (WHO)

WHO Model Lists of Essential Medicines

Guide

The WHO Model Lists of Essential Medicines has been updated every two years since 1977. The current versions are the 20th WHO Essential Medicines List (EML) and the 6thWHO Essential Medicines List for Children (EMLc) updated in March 2017.

Published by: World Health Organization (WHO)

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents

Guide

The World Health Organization (WHO) has developed Guidelines for the pharmacologic and radiotherapeutic management of cancer pain in adults and adolescents to provide evidence-based guidance to initiating and managing cancer pain. The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. 

Published by: World Health Organization (WHO)

Ari - Virtual Assistant